Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes

Cites (275)

Items 201–275 of 275

1. Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey
   Richard E. Frye, Swapna Sreenivasula, James B. Adams · 2011 · BMC Pediatrics
2. Children with autism spectrum disorders (ASD) who exhibit chronic gastrointestinal (GI) symptoms and marked fluctuation of behavioral symptoms exhibit distinct innate immune abnormalities and transcriptional profiles of peripheral blood (PB) monocytes
   Jyonouchi, Harumi, Geng, Lee, Streck, Deanna L., Toruner, Gokce A. · 2011 · Journal of Neuroimmunology
3. Treatment for Sleep Problems in Children with Autism and Caregiver Spillover Effects
   John Mick Tilford, Nalin Payakachat, Karen A. Kuhlthau, Jeffrey M. Pyne, Erica A. Kovacs, Jayne B. Bellando, David Keith Williams, Werner B. F. Brouwer, Richard E. Frye · 2015 · Journal of Autism and Developmental Disorders
4. Tetrahydrobiopterin as a Novel Therapeutic Intervention for Autism
   Richard E. Frye, Lynne C. Huffman, Glen R. Elliott · 2010 · Neurotherapeutics
5. Untitled work
   2015 · PubMed
6. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children
   Mostafa, Gehan Ahmed, Al-Ayadhi, Laila Yousef · 2012 · European Journal of Paediatric Neurology
7. Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats
   Klaus‐Peter Ossenkopp, Kelly A. Foley, James Gibson, Melissa A. Fudge, Martin Kavaliers, Donald Peter Cain, Derrick F. MacFabe · 2011 · Behavioural Brain Research
8. Mortality in Individuals With Autism, With and Without Epilepsy
   Jane Pickett, Ellen Xiu, Roberto F. Tuchman, Géraldine Dawson, Clara Lajonchere · 2011 · Journal of Child Neurology
9. Tetrahydrobiopterin as a Treatment for Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled Trial
   Cheryl Klaiman, Lynne C. Huffman, Lauren Masaki, Glen R. Elliott · 2013 · Journal of Child and Adolescent Psychopharmacology
10. A Case of Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
    Susan Perlmutter, Marjorie A. Garvey, F. Xavier Castellanos, Barbara B. Mittleman, Jay N. Giedd, Judith L. Rapoport, Susan E. Swedo · 1998 · American Journal of Psychiatry
11. Population- and Family-Based Studies Associate the MTHFR Gene with Idiopathic Autism in Simplex Families
    Liu, Xudong, Solehdin, Fatima, Cohen, Ira L., Gonzalez, Maripaz G., Jenkins, Edmund C., Lewis, M. E. Suzanne, Holden, Jeanette J. A. · 2011 · Journal of Autism and Developmental Disorders
12. Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism
    Mohammad-Reza Mohammadi, Nourrollah Yadegari, Elmira Hassanzadeh, Mehdi Farokhnia, Habibeh Yekehtaz, Omid Mirshafiee, Shahin Akhondzadeh · 2013 · Clinical Neuropharmacology
13. Long-Term Treatment with Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children and Adolescents with Autism Spectrum Disorder: An Open-Label Extension Study
    Myriam Harfterkamp, Jan K. Buitelaar, Ruud B. Minderaa, Gigi H.H. van de Loo-Neus, Rutger Jan van der Gaag, Pieter J. Hoekstra · 2013 · Journal of Child and Adolescent Psychopharmacology
14. Biomarkers of Abnormal Energy Metabolism in Children with Autism Spectrum Disorder
    Richard E. Frye · 2012 · North American Journal of Medicine and Science
15. The MTHFR 677C→T polymorphism and behaviors in children with autism: exploratory genotype–phenotype correlations
    Robin P. Goin‐Kochel, Anne E. Porter, Sarika U. Peters, Marwan S. Shinawi, Trilochan Sahoo, Arthur L. Beaudet · 2009 · Autism Research
16. Alterations in lipid profile of autistic boys: a case control study
    Kim, Eun-Kyung, Neggers, Yasmin H., Shin, Cheung-Soo, Kim, Eunkyeong, Kim, Eun Mi · 2010 · Nutrition Research
17. Autism Spectrum Disorder: Correlation between aberrant behaviors, EEG abnormalities and seizures
    Michelle Hartley-McAndrew, Arie Weinstock · 2010 · Neurology International
18. Epigenomic programing: a future way to health?
    Shenderov Ba, Tore Midtvedt · 2014 · Microbial Ecology in Health and Disease
19. Potential etiologic factors of microbiome disruption in autism
    Buie, Timothy · 2015 · Clinical Therapeutics
20. Intravenous immunoglobulin therapy in intractable childhood epilepsy: Open-label study and review of the literature
    Mohamad A. Mikati, Rana Kurdi, Ziad El Khoury, Amal C. Rahi, Wissam N. Raad · 2009 · Epilepsy & Behavior
21. An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder
    Craig A. Erickson, Maureen C. Early, Kimberly A. Stigler, Logan K. Wink, Jennifer E. Mullett, Christopher J. McDougle · 2011 · Journal of Child and Adolescent Psychopharmacology
22. Frequency and Clinical Correlates of Sleep-Related Problems Among Anxious Youth with Autism Spectrum Disorders
    Joshua M. Nadeau, Elysse B. Arnold, Amanda C. Keene, Amanda B. Collier, Adam B. Lewin, Tanya K. Murphy, Eric A. Storch · 2014 · Child Psychiatry & Human Development
23. Mitochondrial Energy-Deficient Endophenotype in Autism
    John Jay Gargus, Faiqa Imtiaz · 2008 · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology
24. Digestive Enzyme Supplementation for Autism Spectrum Disorders: A Double-Blind Randomized Controlled Trial
    Sujeeva A. Munasinghe, Carolyn Oliff, Judith Finn, John A. Wray · 2010 · Journal of Autism and Developmental Disorders
25. A Randomized, Placebo-controlled Trial of Digestive Enzymes in Children with Autism Spectrum Disorders
    Khaled Saad, Azza A. Eltayeb, Ismail Lotfy Mohamad, Abdulrahman Abdullah Al-Atram, Yasser Elserogy, Geir Bjørklund, Amira A. Elhoufey, Bubba Nicholson · 2015 · Clinical Psychopharmacology and Neuroscience
26. Immunoglobulin treatment in epilepsy, a review of the literature
    Baziel G.M. van Engelen, W.O. Renier, Corry M.R. Weemaes, Fons J.M. Gabreëls, H. Meinardi · 1994 · Epilepsy Research
27. Can sodium valproate improve learning in children with epileptiform bursts but without clinical seizures?
    Gabriel M. Ronen, Joanne Richards, Charles Cunningham, Margaret Secord, David Rosenbloom · 2000 · Developmental Medicine & Child Neurology
28. Valproic Acid Treatment of Epilepsy in Autistic Twins
    Judith A. Childs, Joan L. Blair · 1997 · Journal of Neuroscience Nursing
29. 5q14.3 Deletion Manifesting as Mitochondrial Disease and Autism: Case Report
    Herbert Ezugha, Michael J. Goldenthal, Ignacio Valencia, Carol E. Anderson, Agustín Legido, Harold G. Marks · 2010 · Journal of Child Neurology
30. Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin
    Sudhir Gupta, Daljeet Samra, Sudhanshu Agrawal · 2010 · Journal of Clinical Immunology
31. Corticosteroid therapy in regressive autism: a retrospective study of effects on the Frequency Modulated Auditory Evoked Response (FMAER), language, and behavior
    Frank Hopkins Duffy, Aditi Shankardass, Gloria B. McAnulty, Yaman Z. Ekşioğlu, David L. Coulter, Alexander Rotenberg, Heidelise Als · 2014 · BMC Neurology
32. Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome
    Richard E. Frye, Devin M. Cox, John M. Slattery, Marie Tippett, Stephen G. Kahler, Doreen Granpeesheh, Shirish Damle, Agustín Legido, Michael J. Goldenthal · 2016 · Scientific Reports
33. Tetrahydrobiopterin in the Treatment of Children With Autistic Disorder
    Torsten Danfors, Anne-Liis von Knorring, Per Hartvig, Bengt Långström, Robert Moulder, Bo Strömberg, Richard Torstenson, Ulrika Wester Oxelgren, Yasuyoshi Watanabe, Orvar Eeg‐Olofsson · 2005 · Journal of Clinical Psychopharmacology
34. Enzyme-based therapy for autism spectrum disorders – Is it worth another look?
    Mark A. Brudnak, Bernard Rimland, Roy E. Kerry, Margaret E. Dailey, Robert M. Taylor, Bruce Stayton, Frank Waickman, Michael Waickman, Jon Pangborn, Ilene Buchholz · 2002 · Medical Hypotheses
35. Use of Intravenous Immunoglobulin in the Treatment of Twelve Youths with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections
    Miro Kovacevic, Paul Grant, Susan E. Swedo · 2015 · Journal of Child and Adolescent Psychopharmacology
36. mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders
    Lindsay M. Oberman · 2012 · Expert Opinion on Investigational Drugs
37. Increased Susceptibility to Ethylmercury-Induced Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines
    Shannon Rose, Rebecca A. Wynne, Richard E. Frye, Stepan Melnyk, S. Jill James · 2015 · Journal of Toxicology
38. The two fold role of oxytocin in social developmental disorders: A cause and a remedy?
    Arthur Lefèvre, Angela Sirigu B · 2016 · Neuroscience & Biobehavioral Reviews
39. Increased Anti-Phospholipid Antibodies in Autism Spectrum Disorders
    Milo Careaga, Robin L Hansen, Irva Hertz-Piccotto, Judy Van de Water, Paul Ashwood · 2013 · Mediators of Inflammation
40. Magnetoencephalographic pattern of epileptiform activity in children with early-onset autism spectrum disorders
    J A Muñoz-Yunta, Tomás Ortiz, Montserrat Palau-Baduell, L. Martín-Muñoz, B Salvadó-Salvadó, Antonio Valls-Santasusana, J. Perich-Alsina, Isabel Cristóbal, Alberto Fernández, Fernando Maestú et al. · 2008 · Clinical Neurophysiology
41. Plasma Concentration of Immunoglobulin Classes and Subclasses in Children with Autism in the Republic of Macedonia: Retrospective Study
    Vladimir Trajkovski, Ljubomir Ajdinski, Mirko Zhivko Spiroski · 2018
42. A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder
    Benjamin L. Handen, Raun D. Melmed, Robin L Hansen, Michael G. Aman, David L. Burnham, JON B. BRUSS, Christopher J. McDougle · 2009 · Journal of Autism and Developmental Disorders
43. INVESTIGATION OF THE RELATION BETWEEN ANAEROBIC BACTERIA GENUSCLOSTRIDIUMAND LATE-ONSET AUTISM ETIOLOGY IN CHILDREN
    Recep Keşli, Cem Gökçen, Ufuk Buluğ, Yüksel Terzi · 2013 · Journal of Immunoassay and Immunochemistry
44. Epigenomics and the Microbiota
    Theresa Alenghat · 2014 · Toxicologic Pathology
45. Neonatally measured immunoglobulins and risk of autism
    Judith K. Grether, Lisa Croen, Meredith Anderson, Karin B. Nelson, Robert H. Yolken · 2010 · Autism Research
46. Acquired Microcephaly, Regression of Milestones, Mitochondrial Dysfunction, and Episodic Rigidity in a 46,XY Male With a De Novo MECP2 Gene Mutation
    John M. Condie, Joshua L. Goldstein, Mark S. Wainwright · 2010 · Journal of Child Neurology
47. Complicated relationship between autism with regression and epilepsy.
    Hana Ošlejšková, Ladislav Dušek, Zuzana Makovská, Jana Pejčochová, Rudolf Autrata, Ivo Šlapák · 2008 · PubMed
48. Atomoxetine in Autism Spectrum Disorder: No Effects on Social Functioning; Some Beneficial Effects on Stereotyped Behaviors, Inappropriate Speech, and Fear of Change
    Myriam Harfterkamp, Jan K. Buitelaar, Ruud B. Minderaa, Gigi H.H. van de Loo-Neus, Rutger Jan van der Gaag, Pieter J. Hoekstra · 2014 · Journal of Child and Adolescent Psychopharmacology
49. The Role of Oxytocin in Parenting and as Augmentative Pharmacotherapy: Critical Issues and Bold Conjectures
    Marinus H. van IJzendoorn, Marian J. Bakermans‐Kranenburg · 2015 · Journal of Neuroendocrinology
50. Clinical potential, safety, and tolerability of arbaclofen in the treatment of autism spectrum disorder
    Richard E. Frye · 2014 · Drug Healthcare and Patient Safety
51. Therapeutic effect of tetrahydrobiopterin in infantile autism.
    Hiroshi Naruse, Tokishi Hayashi, Masashi Takesada · 1987 · Proceedings of the Japan Academy Series B
52. The complementary role of high sensitivity C-reactive protein in the diagnosis and severity assessment of autism
    Mohammad Reza Khakzad, Maryam Javanbakht, Mohammad Reza Shayegan, Sina Kianoush, Fatemeh Omid, Maryam Hojati, Mojtaba Meshkat · 2012 · Research in Autism
53. Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder
    Craig A. Erickson, Logan K. Wink, Maureen C. Early, Elizabeth Stiegelmeyer, Lauren Mathieu-Frasier, Vanessa B. Patrick, Christopher J. McDougle · 2013 · Journal of Autism and Developmental Disorders
54. Electroencephalogram Discharges in Atypical Cognitive Development
    Richard E. Frye, Ian J. Butler, David Strickland · 2010 · Journal of Child Neurology
55. Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction
    Heuer, Luke S., Rose, Melissa, Ashwood, Paul, Van de Water, Judy · 2012 · Journal of Neuroimmunology
56. 15q11.2-13 Duplication, Mitochondrial Dysfunction, and Developmental Disorders
    Richard E. Frye · 2009 · Journal of Child Neurology
57. A model for the induction of autism in the ecosystem of the human body: the anatomy of a modern pandemic?
    Staci D. Bilbo, Cynthia D. Nevison, William Parker · 2015 · Microbial Ecology in Health and Disease
58. Central tetrahydrobiopterin concentration in neurodevelopmental disorders
    Frye · 2010 · Frontiers in Neuroscience
59. Immunoglobulins as an Alternative Strategy of Psychopharmacological Treatment of Children with Autistic Disorder
    Helmut Niederhofer, Wolfgang Staffen, A. Mair · 2002 · Neuropsychopharmacology
60. Mitochondrial Disease in 22q13 Duplication Syndrome
    Richard E. Frye · 2012 · Journal of Child Neurology
61. Metabolic profiles in adults with autism spectrum disorder and intellectual disabilities
    Leena Moses, Nachum Katz, Abraham Weizman · 2013 · European Psychiatry
62. Identifying Essential Cell Types and Circuits in Autism Spectrum Disorders
    Susan E. Maloney, Michael A. Rieger, Joseph D. Dougherty · 2013 · International review of neurobiology
63. Improvement in children with autism treated with intravenous gamma globulin
    Marvin Boris, Allan Goldblatt, Stephen M. Edelson · 2005 · Journal of Nutritional & Environmental Medicine
64. Resistant Catatonia in a High-Functioning Autism Spectrum Disorder Patient Successfully Treated with Amantadine
    Pierre Ellul, Jean‐Yves Rotgé, Walid Choucha · 2015 · Journal of Child and Adolescent Psychopharmacology
65. Treatment Resistant Epilepsy in Autism Spectrum Disorder: Increased Risk for Females
    Karen Blackmon, Judith Bluvstein, William S. MacAllister, Jennifer Avallone, Jade Misajon, Julie Hedlund, Rina Goldberg, Aviva Bojko, Nirmala Mitra, Radha Giridharan et al. · 2015 · Autism Research
66. Efficacy of Atomoxetine for the Treatment of ADHD Symptoms in Patients With Pervasive Developmental Disorders
    Alberto Fernández‐Jaén, Daniel Martı́n Fernández-Mayoralas, Beatriz Calleja‐Pérez, Nuria Muñoz Jareño, María del Rosario Campos Díaz, Sonia López-Arribas · 2012 · Journal of Attention Disorders
67. Drugmakers dance with autism
    Sarah Webb · 2010 · Nature Biotechnology
68. Endothelial antibody levels in the sera of children with autism spectrum disorders
    Shahid Bashir, Laila Yousef AL-Ayadhi · 2015 · Journal of the Chinese Medical Association
69. Serum antinucleosome-specific antibody as a marker of autoimmunity in children with autism
    Laila Yousef AL-Ayadhi, Gehan Ahmed Mostafa · 2014 · Journal of Neuroinflammation
70. A genomic view on epilepsy and autism candidate genes
    Kamel Jabbari, Peter Nürnberg · 2016 · Genomics
71. Family Analysis of Immunoglobulin Classes and Subclasses in Children with Autistic Disorder
    Mirko Zhivko Spiroski, Vladimir Trajkovski, Дејан Трајков, Александар Петличковски, Оливија Ефинска-Младеновска, Slavica Hristomanova, Eli Djulejic, Meri Paneva, Jadranka Božikov · 2009 · Bosnian Journal of Basic Medical Sciences
72. Seizure-induced neuronal injury: Vulnerability to febrile seizures in an immature rat model
    Zsuzsanna Tóth, Yan Xx, Ce Ribak, TZ Baram · 1998
73. A Randomized, Double-Blind Comparison of Atomoxetine and Placebo on Response Inhibition and Interference Control in Children and Adolescents With Autism Spectrum Disorder and Comorbid Attention-Deficit/Hyperactivity Disorder Symptoms
    Jolanda M. J. van der Meer, Myriam Harfterkamp, Gigi H.H. van de Loo-Neus, Monika Althaus, Saskia W. de Ruiter, A. Rogier T. Donders, Leo M. J. de Sonneville, Jan K. Buitelaar, Pieter J. Hoekstra, Nanda N. J. Rommelse · 2013 · Journal of Clinical Psychopharmacology
74. Prevalence of Resistence to Activated Protein C (Apc-Resistance) in Blood Donors in Kosovo
    Ymer Mekaj, Bukurije Zhubi, Hakif Hoxha, Remzije Belegu, Ermira Miftari, Mazllum Belegu · 2009 · Bosnian Journal of Basic Medical Sciences
75. GASTROESOPHAGEAL REFLUX IN CHILDREN WITH AUTISM: HOW DO CHILDREN PRESENT AND CAN ONE TEST THESE CHILDREN?
    Timothy M. Buie · 2005 · Journal of Pediatric Gastroenterology and Nutrition